Kitron ASA (0F0J)
London Exchange · UK · prices in NOK · close of 21 Oct 2026
Key indicators
| Last close | NOK 95.20 |
|---|---|
| 52-week range | 56.73 – 116.10 |
| Return, 1 month / 3 months | −3.5% / +7.6% |
| Return, 1 year / 3 years | +56.5% / +176.2% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 42.0% |
| Worst drawdown (1 year) | -28.2% |
| Average daily value traded | 6.44M NOK |
| Dividend yield | 0.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Kitron ASA is an electronics manufacturing services company based in Norway. It builds electronic components, assemblies and complete products for customers in industries such as defence and aerospace, energy, medical technology and industrial equipment. The company works with original equipment manufacturers that outsource production, and it operates manufacturing sites in several European countries as well as in the United States and Asia. Its services cover the whole production process, from design support through manufacturing to testing and after-sales service.
The shares are listed on the London Exchange in UK under the code 0F0J, and the price on this page is in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Kitron ASA (0F0J) trades on the London Exchange in UK. It last closed at NOK 95.20 on 21 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 1,868 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 56.5% and over the last three months it rose 7.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 45 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -1.9% | ||
| From 52-week high | -16.7% | ||
| Momentum | 64 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 7.6% | ||
| 6-month return | -10.7% | ||
| 12-month return, skipping the last month | 62.2% | ||
| Stability (higher is calmer) | 45 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 42.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.2% | ||
| Liquidity | 70 · Strong | Trades actively. | |
| Average daily value traded | 6.44M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | 42 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.7% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −7.5% |
|---|---|
| 1 month | −3.5% |
| 3 months | +7.6% |
| 6 months | −10.7% |
| 1 year | +56.5% |
| 3 years | +176.2% |
| 5 years | – |
Signals
| 50-day / 200-day average | 96.52 / 97.07 |
|---|---|
| Golden / death cross (60 days) | Death, 33 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.69 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Apr 2026 | NOK 0.7000 |
| 25 Apr 2025 | NOK 0.3500 |
| 26 Apr 2024 | NOK 0.7500 |
| 2 May 2023 | NOK 0.5000 |
| 28 Apr 2022 | NOK 0.2500 |
| 5 Oct 2021 | NOK 0.3500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.